Which laboratory tests should be ordered for suspected poisoning with Visine (tetrahydrozoline) eye drops?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Laboratory Testing for Suspected Tetrahydrozoline (Visine) Poisoning

For suspected tetrahydrozoline poisoning, order both serum and urine samples for specific tetrahydrozoline quantification using gas chromatography-mass spectrometry (GC-MS), with urine being the preferred specimen for detection up to 24 hours post-exposure.

Specific Testing Recommendations

Primary Tests

  • Urine tetrahydrozoline level by GC-MS - This is your most reliable test 1, 2

    • Detectable for up to 24 hours after exposure
    • Therapeutic ocular use produces concentrations of 13-210 ng/mL at 24 hours 1
    • Toxic ingestions produce significantly higher levels (>100 ng/mL detected 20 hours post-exposure in assault cases) 2
    • Concentrations exceeding the 95% confidence interval of therapeutic use suggest intentional poisoning 1
  • Serum tetrahydrozoline level by GC-MS - Less sensitive but useful if obtained early 1, 3

    • Half-life approximately 4.4-6 hours 1, 3
    • Therapeutic ocular use: maximum serum concentrations 0.068-0.380 ng/mL 1
    • Toxic ingestions: 23.6-51.4 ng/mL reported in pediatric cases 3
    • May be undetectable by 20 hours post-exposure 2

Critical Timing Considerations

Collect specimens immediately - tetrahydrozoline clears rapidly from the body 2, 4. In suspected drug-facilitated assault cases, toxicology screening should be performed as soon as possible, potentially even before completing the full history and physical examination 5, 6.

Supporting Laboratory Tests

Baseline Assessment

  • Complete metabolic panel - assess for metabolic derangements
  • Liver function tests (AST, ALT) - evaluate hepatic involvement
  • Electrolytes - particularly sodium (may show abnormalities in poisoning) 7
  • Complete blood count - assess hematologic parameters 7

Cardiac Monitoring

  • Serial ECGs - tetrahydrozoline causes bradycardia, hypotension, and can produce complete heart block 8
  • Monitor for QT prolongation and conduction abnormalities 8

Comprehensive Toxicology Screen

  • Expanded urine drug screen - tetrahydrozoline is NOT included in standard drug screening panels 5, 6
  • Blood alcohol level - commonly co-ingested in assault cases 4
  • Benzodiazepine and antihistamine screening - frequently used concomitantly in drug-facilitated assaults 5, 6

Important Clinical Caveats

Laboratory Limitations

Standard immunoassay drug screens will not detect tetrahydrozoline 5. You must specifically request GC-MS analysis for imidazoline derivatives 9. Contact your laboratory or state forensic laboratory before specimen collection to ensure proper handling and chain of custody 5, 6.

Specimen Collection Protocol

For forensic cases (suspected assault):

  • Collect both blood and urine immediately
  • Maintain proper chain of custody
  • Urine is superior to blood for late presentations (>12 hours) 2
  • Document exact time of collection relative to suspected exposure

Interpretation Pitfall

A negative standard toxicology screen does not rule out tetrahydrozoline poisoning. The drug requires specific testing methodology that most emergency departments do not routinely perform 5, 6.

Clinical Context

Laboratory diagnosis is based on exclusion of alternative causes combined with clinical presentation 10. The classic toxidrome includes:

  • CNS depression with periods of intermittent consciousness 2
  • Bradycardia and hypotension 3, 8
  • Hypothermia 3
  • Post-exposure vomiting 2

Management decisions (such as supportive care, cardiac monitoring) should be made on clinical grounds, not delayed pending laboratory confirmation 11.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.